Samuel E. Gandy, MD PhD

Affiliations: 
Neurology and Psychiatry Icahn School of Medicine at Mount Sinai, New York, NY, United States 
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=74
Website:
http://www.mountsinai.org/profiles/samuel-e-gandy?id=0000072500003639565131
Google:
"Samuel Gandy"
Cross-listing: Neurotree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Beckmann ND, Lin WJ, Wang M, et al. (2020) Multiscale causal networks identify VGF as a key regulator of Alzheimer's disease. Nature Communications. 11: 3942
Kritikos M, Clouston SAP, Diminich ED, et al. (2020) Pathway Analysis for Plasma β-Amyloid, Tau and Neurofilament Light (ATN) in World Trade Center Responders at Midlife. Neurology and Therapy
Woo YJ, Roussos P, Haroutunian V, et al. (2020) Comparison of brain connectomes by MRI and genomics and its implication in Alzheimer's disease. Bmc Medicine. 18: 23
El Gaamouch F, Audrain M, Lin WJ, et al. (2020) VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice. Molecular Neurodegeneration. 15: 4
Readhead B, Haure-Mirande JV, Ehrlich ME, et al. (2019) Clarifying the Potential Role of Microbes in Alzheimer's Disease. Neuron. 104: 1036-1037
Hata S, Omori C, Kimura A, et al. (2019) Decrease in p3-Alcβ37 and p3-Alcβ40, products of Alcadein β generated by γ-secretase cleavages, in aged monkeys and patients with Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 5: 740-750
Clouston SAP, Deri Y, Diminich E, et al. (2019) Posttraumatic stress disorder and total amyloid burden and amyloid-β 42/40 ratios in plasma: Results from a pilot study of World Trade Center responders. Alzheimer's & Dementia (Amsterdam, Netherlands). 11: 216-220
Haure-Mirande JV, Wang M, Audrain M, et al. (2018) Correction: Integrative approach to sporadic Alzheimer's disease: deficiency of TYROBP in cerebral Aβ amyloidosis mouse normalizes clinical phenotype and complement subnetwork molecular pathology without reducing Aβ burden. Molecular Psychiatry
Haure-Mirande JV, Wang M, Audrain M, et al. (2018) Integrative approach to sporadic Alzheimer's disease: deficiency of TYROBP in cerebral Aβ amyloidosis mouse normalizes clinical phenotype and complement subnetwork molecular pathology without reducing Aβ burden. Molecular Psychiatry
Audrain M, Haure-Mirande JV, Wang M, et al. (2018) Integrative approach to sporadic Alzheimer's disease: deficiency of TYROBP in a tauopathy mouse model reduces C1q and normalizes clinical phenotype while increasing spread and state of phosphorylation of tau. Molecular Psychiatry
See more...